J. Wedzicha

Pulmonary and Respiratory Medicine · 2000–2023

A researcher in the Science corpus: 19 papers; trusts 4 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

• Pulmonary and Respiratory Medicine — 202 citations into it; #81 of 770 by trust here, #73 by citations
• Physiology — 103 citations into it; #1,041 of 2,276 by trust here, #753 by citations
• Issues, ethics and legal aspects — 6 citations into it

Whom J. Wedzicha trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Calverley
2. R. Rodríguez-Roisín
3. T. Seemungal
4. Jorgen Vestbo
5. G. Donaldson

Who trusts J. Wedzicha overall

1. D. Parums
2. K. Rabe
3. Bartolome Celli
4. P. Barnes
5. A. Anzueto

Papers from J. Wedzicha's perspective

Ordered by how strongly the researchers J. Wedzicha trusts endorse each paper. Same corpus, a different order for every researcher.

1. Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
2. Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
4. Health status measurement in chronic obstructive pulmonary disease (Thorax)
5. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. (New England Journal of Medicine)
6. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report (Respirology (Carlton South. Print))
7. Risk of myocardial infarction and stroke after acute infection or vaccination. (New England Journal of Medicine)
8. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. (The Lancet)
9. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. (American Journal of Respiratory and Critical Care Medicine)
10. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. (The Lancet Respiratory Medicine)

Their papers

• Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease (2002) — 2,378 citations
• Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations (2000) — 805 citations
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023) — 849 citations
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023) — 865 citations
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (2019) — 1,914 citations
• Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report (2017) — 1,216 citations
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (2017) — 3,443 citations
• Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline (2017) — 596 citations
• Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. (2016) — 831 citations
• Susceptibility to exacerbation in chronic obstructive pulmonary disease. (2010) — 2,914 citations
• The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. (2008) — 882 citations
• COPD exacerbations: defining their cause and prevention (2007) — 1,169 citations
• Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey (2005) — 634 citations
• Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. (2004) — 727 citations
• Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis (2003) — 810 citations
• COPD exacerbations: definitions and classifications (2003) — 694 citations
• Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations (2002) — 739 citations
• Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. (2001) — 1,079 citations
• Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. (2000) — 1,282 citations